J Gynecol Oncol.  2018 Jan;29(1):e2. 10.3802/jgo.2018.29.e2.

Robotic single site radical hysterectomy plus pelvic lymphadenectomy in gynecological cancers

Affiliations
  • 1Department of Experimental Clinical Oncology, Gynecologic Oncology Unit, “Regina Elena” National Cancer Institute, Rome, Italy.
  • 2Department of Health of Woman and Child, Gynecologic Oncology Unit, Catholic University of the Sacred Heart, Rome, Italy. giacomo.corrado@alice.it

Abstract


OBJECTIVE
To evaluate the feasibility and the safety of robotic single-site radical hysterectomy (RSSRH) plus pelvic lymphadenectomy (PL) in endometrial or cervical cancer.
METHODS
Patients with endometrial cancer (EC) International Federation of Gynecology and Obstetrics (FIGO) stage II, early cervical cancer (ECC) FIGO stage IB1 or locally advanced cervical cancer (LACC) FIGO stage IB2-IIB with clinical response ≥50% after neo-adjuvant chemotherapy (NACT) were enrolled in a prospective cohort trial. All cases were performed using the da Vinci Si Surgical Single Site System®.
RESULTS
Between April 2014 and November 2016, twenty patients were included in our pilot study. Three and 17 patients underwent type B1 or C1 RSSRH plus PL, respectively. The median age of patients was 46 years (range, 36-68 years) and the median body mass index was 23.5 kg/m2 (range, 19.1-36.3 kg/m2). The median total operative time was 190 minutes (range, 90-310 minutes). The median blood loss was 75 mL (range, 20-700 mL) and the median number of pelvic lymph nodes removed was 16 (range, 5-27). No laparoscopic/laparotomic conversions were reported and the median time to discharge was 6 days (range, 4-16 days). No intra-operative complications occurred while 4 (20%) post-operative complications were reported: one pelvic abscess, one lymphorrea, one bowel perforation, and one vaginal dehiscence.
CONCLUSION
RSSRH plus PL is technically feasible in patients affected by gynecological cancer.

Keyword

Robotic Surgical Procedures; Hysterectomy; Lymph Node Excision; Uterine Cervical Neoplasms; Endometrial Neoplasms

MeSH Terms

Abscess
Body Mass Index
Cohort Studies
Drug Therapy
Endometrial Neoplasms
Female
Gynecology
Humans
Hysterectomy*
Lymph Node Excision*
Lymph Nodes
Obstetrics
Operative Time
Pilot Projects
Prospective Studies
Robotic Surgical Procedures
Uterine Cervical Neoplasms
Full Text Links
  • JGO
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr